Evidence map›Paper›PMID 32602058›Full record

ArticleCancer causes & control : CCC2020

Use of cervical cancer preventive services among US women aged 21-29: an assessment of the 2010 Affordable Care Act rollout through 2018.

Carlos O Garrido, Rebekah A Coşkun, Adrienne B Lent, Elizabeth Calhoun, Robin B Harris

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer causes & control : CCC, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Racial Differences in Expected Versus Actual Costs of Cervical Cancer Screening among Low-Income, Underscreened Women in North Carolina.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Reducing Poverty-Related Disparities in Cervical Cancer: The Role of HPV Vaccination.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carlos O GarridoArizona Cancer Center, University of Arizona, 1515 N Campbell Ave, Tucson, AZ, 85719, USA. carlosgarrido@email.arizona.edu.ORCID http://orcid.org/0000-0002-8509-6800
Rebekah A CoşkunArizona Cancer Center, University of Arizona, 1515 N Campbell Ave, Tucson, AZ, 85719, USA.
Adrienne B LentArizona Cancer Center, University of Arizona, 1515 N Campbell Ave, Tucson, AZ, 85719, USA.
Elizabeth CalhounArizona Cancer Center, University of Arizona, 1515 N Campbell Ave, Tucson, AZ, 85719, USA.
Robin B HarrisArizona Cancer Center, University of Arizona, 1515 N Campbell Ave, Tucson, AZ, 85719, USA.

Funding

Cancer Prevention and Control Health Disparities Training ProgramT32CA078447 · NCI · UNIVERSITY OF ARIZONA · PI ALBERTS, DAVID SAMUEL, HARRIS, ROBIN B · 2016 to 2020
$1.2M
NCI NIH HHS T32 CA078447NCI NIH HHS T32CA078447
6 · The paper itself

Abstract

purposeThe 2010 Affordable Care Act (ACA) provided millions of people with health insurance coverage and facilitated routine cancer screening by requiring insurers to cover preventive services without cost-sharing. Despite greater access to affordable cancer screening, Pap testing has declined over time. The aim of this study is to assess participation in Pap test and HPV vaccination, and adherence to guidelines as outlined by the American Cancer Society (ACS) from the 2010 ACA provision eliminating cost-sharing for preventive services.

methodsUsing multi-year responses from the Behavioral Risk Factor Surveillance System, we examined the association between the ACA and participation in and adherence to Pap testing and HPV vaccination behaviors as set by the ACS. The sample included women aged 21-29 who completed the survey between 2008 and 2018 (every other year) and who live in 24 US States (N = 37,893).

resultsResults showed significant decreases in Pap testing rates but increases in the uptake of the HPV vaccine series for all age groups and across all demographics. Post-ACA year significantly predicted increases in HPV + Pap co-testing participation and adherence. Women with health insurance coverage were more likely to engage in both behaviors.

conclusionFindings raise concerns around declines in the proportion of women receiving and adhering to Pap testing guidelines. A need exists for research to examine the role of increases in HPV vaccination uptake on decreases in Pap testing. Moreover, effective strategies should target increases in cervical cancer screening uptake among women vaccinated against HPV.

Indexed as

AdultCost SharingCross-Sectional StudiesEarly Detection of CancerFemaleHumansPapanicolaou TestPapillomavirus VaccinesPatient Protection and Affordable Care ActPreventive Health ServicesSurveys and QuestionnairesUnited StatesUterine Cervical NeoplasmsYoung AdultPapillomavirus VaccinesAffordable care actCancer screeningCervical cancerCost-sharingHuman papilloma virus

Identifiers

PMID32602058
PMCPMC7433930

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.